DrugPatentWatch.com Basic Plan - Drug patent expirations dates, exclusivity, sales, patent detals, case histories, and more..

DrugPatentWatch - Online Approved Drug Database

This preview contains a fraction of the information available in the subscriber section and is limited to 5 results per search.

Instant Access with secure payment processing:

$195 / One Month $750 / One Year

Need an invoice? Group rate? Contact admin@DrugPatentWatch.com

Listing of Drug Product Information by Exclusivity Expiration - 2011
Range: 1 - 5

Applicant Tradename Generic Name NDA Approval Date Exclusivity Expiration Patented / Exclusive Use
Alcon PATANASE olopatadine hydrochloride 021861 Apr 15, 2008 Apr 15, 2011 NEW DOSAGE FORM
Vernalis APOKYN apomorphine hydrochloride 021264 Apr 20, 2004 Apr 20, 2011 ORPHAN DRUG EXCLUSIVITY
New River Pharms VYVANSE lisdexamfetamine dimesylate 021977 Dec 10, 2007 Apr 23, 2011 NEW PATIENT POPULATION
New River Pharms VYVANSE lisdexamfetamine dimesylate 021977 Feb 23, 2007 Apr 23, 2011 NEW PATIENT POPULATION
Sucampo Pharms AMITIZA lubiprostone 021908 Apr 29, 2008 Apr 28, 2011 NEW STRENGTH
Complete access available with subscription

2008 2009 2010 2011 2012 2013 2014 2015
All listed trade names are property of their owners or licensors.
Raw information from FDA Orange Book, USPTO and other sources. Copyright © 2008 thinkBiotech LLC

[ Home | Free Patent Expiration Bulletin | Pharmaceutical Innovation Dashboard | Media Access | Affiliate Program | Contact ]
Bookmark This Site

DISCLAIMER:
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek independent professional advice before acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
All trademarks and applicant names are the property of their respective owners or licensors.